The SafeBoosC Phase II Randomised Clinical Trial: A Treatment Guideline for Targeted Near-Infrared-Derived Cerebral Tissue Oxygenation versus Standard Treatment in Extremely Preterm Infants

Adelina Pellicer, Gorm Greisen, Manon Benders, Olivier Claris, Eugene Dempsey, Monica Fumagally, Christian Gluud, Cornelia Hagmann, Lena Hellström-Westas, Simon Hyttel-Sorensen, Petra Lemmers, Gunnar Naulaers, Gerhard Pichler, Claudia Roll, Frank van Bel, Wim van Oeveren, Maria Skoog, Martin Wolf, Topun Austin

69 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The SafeBoosC Phase II Randomised Clinical Trial: A Treatment Guideline for Targeted Near-Infrared-Derived Cerebral Tissue Oxygenation versus Standard Treatment in Extremely Preterm Infants'. Together they form a unique fingerprint.

Medicine & Life Sciences